nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cerebral arteriosclerosis—Ifosfamide—testicular cancer	0.254	0.254	CcSEcCtD
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—testicular cancer	0.0361	0.0361	CcSEcCtD
Nalidixic Acid—Papilloedema—Cisplatin—testicular cancer	0.0238	0.0238	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Ifosfamide—testicular cancer	0.0222	0.0222	CcSEcCtD
Nalidixic Acid—Trauma—Bleomycin—testicular cancer	0.0216	0.0216	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Etoposide—testicular cancer	0.0176	0.0176	CcSEcCtD
Nalidixic Acid—Optic neuritis—Cisplatin—testicular cancer	0.0123	0.0123	CcSEcCtD
Nalidixic Acid—Cholestasis—Ifosfamide—testicular cancer	0.0116	0.0116	CcSEcCtD
Nalidixic Acid—Optic neuritis—Etoposide—testicular cancer	0.0113	0.0113	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Chlorambucil—testicular cancer	0.0107	0.0107	CcSEcCtD
Nalidixic Acid—Injury—Bleomycin—testicular cancer	0.00812	0.00812	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.00737	0.00737	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00728	0.00728	CcSEcCtD
Nalidixic Acid—Swelling—Ifosfamide—testicular cancer	0.00723	0.00723	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Ifosfamide—testicular cancer	0.00706	0.00706	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vinblastine—testicular cancer	0.00667	0.00667	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—testicular cancer	0.00632	0.00632	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Chlorambucil—testicular cancer	0.00631	0.00631	CcSEcCtD
Nalidixic Acid—Psychotic disorder—Ifosfamide—testicular cancer	0.00623	0.00623	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Cisplatin—testicular cancer	0.00609	0.00609	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—testicular cancer	0.00585	0.00585	CcSEcCtD
Nalidixic Acid—Swelling—Etoposide—testicular cancer	0.00571	0.00571	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00568	0.00568	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—testicular cancer	0.0054	0.0054	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00532	0.00532	CcSEcCtD
Nalidixic Acid—Angioedema—Chlorambucil—testicular cancer	0.00531	0.00531	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Etoposide—testicular cancer	0.0052	0.0052	CcSEcCtD
Nalidixic Acid—Leukopenia—Chlorambucil—testicular cancer	0.0052	0.0052	CcSEcCtD
Nalidixic Acid—Convulsion—Chlorambucil—testicular cancer	0.00503	0.00503	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—testicular cancer	0.00499	0.00499	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00487	0.00487	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00482	0.00482	CcSEcCtD
Nalidixic Acid—Vertigo—Vinblastine—testicular cancer	0.00478	0.00478	CcSEcCtD
Nalidixic Acid—Leukopenia—Vinblastine—testicular cancer	0.00476	0.00476	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Chlorambucil—testicular cancer	0.00464	0.00464	CcSEcCtD
Nalidixic Acid—Convulsion—Vinblastine—testicular cancer	0.00461	0.00461	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Dactinomycin—testicular cancer	0.00455	0.00455	CcSEcCtD
Nalidixic Acid—Erythema—Bleomycin—testicular cancer	0.00449	0.00449	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Vinblastine—testicular cancer	0.00425	0.00425	CcSEcCtD
Nalidixic Acid—Visual impairment—Ifosfamide—testicular cancer	0.00425	0.00425	CcSEcCtD
Nalidixic Acid—Erythema—Dactinomycin—testicular cancer	0.00419	0.00419	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Ifosfamide—testicular cancer	0.00417	0.00417	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Cisplatin—testicular cancer	0.00415	0.00415	CcSEcCtD
Nalidixic Acid—Leukopenia—Bleomycin—testicular cancer	0.00402	0.00402	CcSEcCtD
Nalidixic Acid—Paraesthesia—Vinblastine—testicular cancer	0.0039	0.0039	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00388	0.00388	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00385	0.00385	CcSEcCtD
Nalidixic Acid—Erythema—Ifosfamide—testicular cancer	0.00384	0.00384	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Etoposide—testicular cancer	0.00381	0.00381	CcSEcCtD
Nalidixic Acid—Urticaria—Chlorambucil—testicular cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Leukopenia—Dactinomycin—testicular cancer	0.00375	0.00375	CcSEcCtD
Nalidixic Acid—Abdominal pain—Chlorambucil—testicular cancer	0.00375	0.00375	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Bleomycin—testicular cancer	0.00367	0.00367	CcSEcCtD
Nalidixic Acid—Visual impairment—Cisplatin—testicular cancer	0.00367	0.00367	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Bleomycin—testicular cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Vinblastine—testicular cancer	0.00355	0.00355	CcSEcCtD
Nalidixic Acid—Angioedema—Ifosfamide—testicular cancer	0.00351	0.00351	CcSEcCtD
Nalidixic Acid—Vertigo—Ifosfamide—testicular cancer	0.00345	0.00345	CcSEcCtD
Nalidixic Acid—Leukopenia—Ifosfamide—testicular cancer	0.00344	0.00344	CcSEcCtD
Nalidixic Acid—Abdominal pain—Vinblastine—testicular cancer	0.00343	0.00343	CcSEcCtD
Nalidixic Acid—Asthenia—Chlorambucil—testicular cancer	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Pruritus—Chlorambucil—testicular cancer	0.00335	0.00335	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dactinomycin—testicular cancer	0.00335	0.00335	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00334	0.00334	CcSEcCtD
Nalidixic Acid—Convulsion—Ifosfamide—testicular cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Erythema—Cisplatin—testicular cancer	0.00331	0.00331	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—testicular cancer	0.00329	0.00329	CcSEcCtD
Nalidixic Acid—Paraesthesia—Bleomycin—testicular cancer	0.00329	0.00329	CcSEcCtD
Nalidixic Acid—Arthralgia—Ifosfamide—testicular cancer	0.00327	0.00327	CcSEcCtD
Nalidixic Acid—Diarrhoea—Chlorambucil—testicular cancer	0.00324	0.00324	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Ifosfamide—testicular cancer	0.00313	0.00313	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Asthenia—Vinblastine—testicular cancer	0.00312	0.00312	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Ifosfamide—testicular cancer	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Vomiting—Chlorambucil—testicular cancer	0.00301	0.00301	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vinblastine—testicular cancer	0.00297	0.00297	CcSEcCtD
Nalidixic Acid—Leukopenia—Cisplatin—testicular cancer	0.00296	0.00296	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—testicular cancer	0.00295	0.00295	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Nalidixic Acid—Urticaria—Bleomycin—testicular cancer	0.00291	0.00291	CcSEcCtD
Nalidixic Acid—Dizziness—Vinblastine—testicular cancer	0.00287	0.00287	CcSEcCtD
Nalidixic Acid—Convulsion—Cisplatin—testicular cancer	0.00287	0.00287	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—testicular cancer	0.00282	0.00282	CcSEcCtD
Nalidixic Acid—Nausea—Chlorambucil—testicular cancer	0.00281	0.00281	CcSEcCtD
Nalidixic Acid—Paraesthesia—Ifosfamide—testicular cancer	0.00281	0.00281	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dactinomycin—testicular cancer	0.0028	0.0028	CcSEcCtD
Nalidixic Acid—Somnolence—Ifosfamide—testicular cancer	0.00279	0.00279	CcSEcCtD
Nalidixic Acid—Vomiting—Vinblastine—testicular cancer	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—testicular cancer	0.00273	0.00273	CcSEcCtD
Nalidixic Acid—Headache—Vinblastine—testicular cancer	0.00272	0.00272	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—testicular cancer	0.00272	0.00272	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dactinomycin—testicular cancer	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Cisplatin—testicular cancer	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cisplatin—testicular cancer	0.00265	0.00265	CcSEcCtD
Nalidixic Acid—Asthenia—Bleomycin—testicular cancer	0.00263	0.00263	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—testicular cancer	0.00263	0.00263	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Nalidixic Acid—Pruritus—Bleomycin—testicular cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—testicular cancer	0.00258	0.00258	CcSEcCtD
Nalidixic Acid—Nausea—Vinblastine—testicular cancer	0.00258	0.00258	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00256	0.00256	CcSEcCtD
Nalidixic Acid—Urticaria—Ifosfamide—testicular cancer	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Abdominal pain—Ifosfamide—testicular cancer	0.00248	0.00248	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—testicular cancer	0.00248	0.00248	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00246	0.00246	CcSEcCtD
Nalidixic Acid—Asthenia—Dactinomycin—testicular cancer	0.00245	0.00245	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cisplatin—testicular cancer	0.00243	0.00243	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Etoposide—testicular cancer	0.00242	0.00242	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—testicular cancer	0.00238	0.00238	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dactinomycin—testicular cancer	0.00234	0.00234	CcSEcCtD
Nalidixic Acid—Vomiting—Bleomycin—testicular cancer	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—testicular cancer	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Rash—Bleomycin—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalidixic Acid—Dermatitis—Bleomycin—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00231	0.00231	CcSEcCtD
Nalidixic Acid—Asthenia—Ifosfamide—testicular cancer	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—testicular cancer	0.00223	0.00223	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—testicular cancer	0.00222	0.00222	CcSEcCtD
Nalidixic Acid—Pruritus—Ifosfamide—testicular cancer	0.00222	0.00222	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—testicular cancer	0.0022	0.0022	CcSEcCtD
Nalidixic Acid—Nausea—Bleomycin—testicular cancer	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Nalidixic Acid—Vomiting—Dactinomycin—testicular cancer	0.00217	0.00217	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Rash—Dactinomycin—testicular cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Diarrhoea—Ifosfamide—testicular cancer	0.00214	0.00214	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—testicular cancer	0.00213	0.00213	CcSEcCtD
Nalidixic Acid—Dizziness—Ifosfamide—testicular cancer	0.00207	0.00207	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Nalidixic Acid—Nausea—Dactinomycin—testicular cancer	0.00203	0.00203	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.00202	0.00202	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—testicular cancer	0.00201	0.00201	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Nalidixic Acid—Vomiting—Ifosfamide—testicular cancer	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Rash—Ifosfamide—testicular cancer	0.00198	0.00198	CcSEcCtD
Nalidixic Acid—Dermatitis—Ifosfamide—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—testicular cancer	0.00197	0.00197	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—testicular cancer	0.00196	0.00196	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Nalidixic Acid—Nausea—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—testicular cancer	0.00185	0.00185	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—testicular cancer	0.00172	0.00172	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—testicular cancer	0.0017	0.0017	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—testicular cancer	0.0017	0.0017	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—testicular cancer	0.00163	0.00163	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—testicular cancer	0.00161	0.00161	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—testicular cancer	0.00156	0.00156	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—testicular cancer	0.00155	0.00155	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—testicular cancer	0.00145	0.00145	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—testicular cancer	0.000996	0.000996	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—testicular cancer	0.000981	0.000981	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—testicular cancer	0.00095	0.00095	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—testicular cancer	0.000943	0.000943	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—testicular cancer	0.000935	0.000935	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—testicular cancer	0.000934	0.000934	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—testicular cancer	0.000918	0.000918	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—testicular cancer	0.000881	0.000881	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000879	0.000879	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—testicular cancer	0.000875	0.000875	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—testicular cancer	0.000874	0.000874	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—testicular cancer	0.000849	0.000849	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—testicular cancer	0.000824	0.000824	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—testicular cancer	0.000809	0.000809	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—testicular cancer	0.000804	0.000804	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
